Valley National Advisers’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.83M | Sell |
4,688
-54
| -1% | -$22.8K | 0.2% | 95 |
|
|
2026
Q1 | $2.24M | Buy |
4,742
+18
| +0.4% | +$9.06K | 0.29% | 75 |
|
|
2025
Q4 | $2.2M | Sell |
4,724
-63
| -1% | -$29.3K | 0.31% | 72 |
|
|
2025
Q3 | $2.04M | Buy |
4,787
+4,714
| +6,458% | +$1.83M | 0.32% | 93 |
|
|
2025
Q2 | $27K | Sell |
73
-1
| -1% | -$360 | ﹤0.01% | 450 |
|
|
2025
Q1 | $25K | Buy |
74
+1
| +1% | +$322 | ﹤0.01% | 455 |
|
|
2024
Q4 | $21K | Hold |
73
| – | – | ﹤0.01% | 450 |
|
|
2024
Q3 | $29K | Sell |
73
-42
| -37% | -$15.4K | 0.01% | 408 |
|
|
2024
Q2 | $36K | Sell |
115
-17
| -13% | -$5.52K | 0.01% | 440 |
|
|
2024
Q1 | $44K | Sell |
132
-30
| -19% | -$9.17K | 0.01% | 424 |
|
|
2023
Q4 | $43K | Sell |
162
-152
| -48% | -$37.6K | 0.01% | 423 |
|
|
2023
Q3 | $77K | Buy |
314
+18
| +6% | +$4.92K | 0.01% | 333 |
|
|
2023
Q2 | $90K | Buy |
296
+4
| +1% | +$1.11K | 0.02% | 318 |
|
|
2023
Q1 | $84K | Sell |
292
-68
| -19% | -$17.3K | 0.01% | 321 |
|
|
2022
Q4 | $90K | Buy |
360
+31
| +9% | +$6.94K | 0.02% | 314 |
|
|
2022
Q3 | $69K | Buy |
329
+37
| +13% | +$7.37K | 0.01% | 335 |
|
|
2022
Q2 | $51K | Sell |
292
-43
| -13% | -$9.24K | 0.01% | 352 |
|
|
2022
Q1 | $84K | Buy |
335
+145
| +76% | +$36.4K | 0.02% | 300 |
|
|
2021
Q4 | $49K | Sell |
190
-2
| -1% | -$489 | 0.01% | 368 |
|
|
2021
Q3 | $47K | Buy |
192
+21
| +12% | +$5.13K | 0.01% | 352 |
|
|
2021
Q2 | $35K | Buy |
171
+47
| +38% | +$9.58K | 0.01% | 393 |
|
|
2021
Q1 | $23K | Buy |
124
+52
| +72% | +$9.17K | ﹤0.01% | 435 |
|
|
2020
Q4 | $12K | Hold |
72
| – | – | ﹤0.01% | 495 |
|
|
2020
Q3 | $9K | Hold |
72
| – | – | ﹤0.01% | 492 |
|
|
2020
Q2 | $7K | Hold |
72
| – | – | ﹤0.01% | 514 |
|
|
2020
Q1 | $6K | Hold |
72
| – | – | ﹤0.01% | 526 |
|
|
2019
Q4 | $11K | Hold |
72
| – | – | ﹤0.01% | 511 |
|
|
2019
Q3 | $9K | Hold |
72
| – | – | ﹤0.01% | 519 |
|
|
2019
Q2 | $10K | Hold |
72
| – | – | ﹤0.01% | 481 |
|
|
2019
Q1 | $9K | Sell |
72
-48
| -40% | -$6.45K | ﹤0.01% | 485 |
|
|
2018
Q4 | $15K | Buy |
120
+101
| +532% | +$13.6K | ﹤0.01% | 401 |
|
|
2018
Q3 | $3K | Hold |
19
| – | – | ﹤0.01% | 556 |
|
|
2018
Q2 | $2K | Buy |
+19
| New | +$1.92K | ﹤0.01% | 560 |
|
Other funds holding HCA
Valley National Advisers's HCA Position: Q2 2026 in Review
Valley National Advisers reduced its HCA Healthcare (HCA) stake by 1.1% in Q2 2026, selling an estimated $22.8K and leaving 4,688 shares worth $1.83M. The position accounts for 0.2% of the portfolio, ranked #95.
Valley National Advisers first reported a position in HCA in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.24M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Valley National Advisers held 4,688 shares of HCA Healthcare worth $1.83M as of Q2 2026.
- Valley National Advisers sold 54 HCA Healthcare shares in Q2 2026, an estimated $22.8K.
- HCA Healthcare made up 0.2% of Valley National Advisers's portfolio in Q2 2026, its #95 holding.
- Valley National Advisers first reported a position in HCA Healthcare in Q2 2018 and has held it in 33 quarters since.
- Valley National Advisers's HCA Healthcare position peaked at $2.24M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.